Harnessing the immune system via FcÎ³R function in immune therapy: a pathway to next-gen mAbs.

Chenoweth, Alicia M; Wines, Bruce D; Anania, Jessica C; Mark Hogarth, P

Chenoweth, Alicia M; Wines, Bruce D; Anania, Jessica C; Mark Hogarth, P.

Affiliation

Chenoweth AM; Immune Therapies Laboratory, Burnet Institute, Melbourne, Australia.
Wines BD; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia.
Anania JC; St John's Institute of Dermatology, King's College, London, UK.
Mark Hogarth P; Immune Therapies Laboratory, Burnet Institute, Melbourne, Australia.

Immunol Cell Biol ; 98(4): 287-304, 2020 04.

Article in En | MEDLINE | ID: mdl-32157732

Subject(s)

Antibodies, Monoclonal; Immunotherapy; Receptors, IgG/immunology; Animals; Antibodies, Monoclonal/immunology; Antibodies, Monoclonal/therapeutic use; Antibody-Dependent Cell Cytotoxicity/immunology; Betacoronavirus/immunology; COVID-19; Coronavirus Infections/drug therapy; Coronavirus Infections/immunology; Coronavirus Infections/therapy; Humans; Neoplasms/immunology; Neoplasms/therapy; Pandemics; Pneumonia, Viral/immunology; Pneumonia, Viral/therapy; SARS-CoV-2; COVID-19 Drug Treatment

Key words

ADCC; Fc receptors; SARS-CoV-2; immune therapy; monoclonal antibodies; phagocytosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, IgG / Immunotherapy / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google